Live Breaking News & Updates on Crl

Stay informed with the latest breaking news from Crl on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Crl and stay connected to the pulse of your community

Atria Wealth Solutions Inc. Has $511,000 Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)

Atria Wealth Solutions Inc. decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,162 shares of the medical research company’s stock after selling 105 […]

Canada , United-states , Asia-pacific , Williamd-barbo , Shannonm-parisotto , Quarter-for-charles-river-laboratories-international , Charles-river-laboratories-international-stock , Brown-advisory-inc , Charles-river-laboratories-international , Jpmorgan-chase-co , Stratos-wealth-partners , Research-models

Van ECK Associates Corp Has $13.64 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)

Van ECK Associates Corp lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during the period. Van ECK Associates […]

Canada , United-states , Williamd-barbo , Asia-pacific , Robertw-baird , Shannonm-parisotto , Charles-river-laboratories-international-profile , Venturi-wealth-management , Jpmorgan-chase-co , Associates-corp , Operose-advisors , Citigroup

Van ECK Associates Corp Sells 5,418 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)

Van ECK Associates Corp trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 57,679 shares of the medical research company’s stock after selling 5,418 shares during […]

United-states , Canada , Shannonm-parisotto , Asia-pacific , Williamd-barbo , Invesco-ltd , Charles-river-laboratories-international-inc , Charles-river-laboratories-international-company-profile , Charles-river-laboratories-international , Securities-exchange-commission , Allspring-global-investments-holdings , Ariel-investments

Lebrikizumab for Atopic Dermatitis Resubmitted for FDA Approval After Previous Rejection

The decision by Eli Lilly to resubmit lebrikizumab to the FDA for adults and adolescents with eczema is expected to receive a response in the second half of the year.

United-kingdom , Japan , Eli-lilly , Facebook , Drug-administration , European-union , Reports-first-quarter , Raises-full-year-revenue-guidance , Highlights-pipeline , Complete-response-letter , Lebrikizumab-treatment , Atopic-dermatitis

Investment House LLC Has $16.11 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL)

Investment House LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 68,126 shares of the medical research company’s stock after selling 706 shares during the quarter. Charles […]

Canada , United-states , Asia-pacific , Shannonm-parisotto , Williamd-barbo , Securities-exchange-commission , Charles-river-laboratories-international-trading , Research-models , Charles-river-laboratories-international , Operose-advisors , Headlands-technologies , Charles-river-laboratories-international-profile

FDA Issues a CRL for Ketamine's Abbreviated New Drug Application

FDA issued a CRL the abbreviated new drug application of ketamine, which had sought to enhance accessibility to the limited drug supply.

Canada , Pharmather-fabio-chinaelli , Drug-administration , Complete-response-letter , Medicines-list , Pain , Mental-health , Psychiatric-disorders , Ketamine , Racemic-ketamine , Anda , Abbreviated-drug-application

Valmark Advisers Inc. Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)

Valmark Advisers Inc. bought a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,000 shares of the medical research company’s stock, valued at approximately $709,000. Other hedge funds […]

Canada , United-states , Asia-pacific , Robertw-baird , Dekabank-deutsche-girozentrale , Shannonm-parisotto , Investment-management , Manufacturing-solutions , Valmark-advisers-inc , Securities-exchange-commission , Charles-river-laboratories-international-stock , Regency-capital-management-inc

CNB Bank Has $700,000 Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)

CNB Bank boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,962 shares of the medical research company’s stock after purchasing an additional 263 shares during the period. CNB Bank’s holdings in Charles […]

United-states , Canada , Shannonm-parisotto , Williamd-barbo , Asia-pacific , Robertw-baird , Pricet-rowe-associates-inc , Jpmorgan-chase-co , Charles-river-laboratories-international-company-profile , Manufacturing-solutions , Charles-river-laboratories-international , Charles-river-laboratories-international-stock-down

Charles River Laboratories International, Inc. (NYSE:CRL) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The […]

United-states , Canada , Asia-pacific , Shannonm-parisotto , Robertw-baird , Jpmorgan-chase-co , Charles-river-laboratories-international-company-profile , Norges-bank , Research-models , Charles-river-laboratories-international , Charles-river-laboratories-international-stock-down , Pricet-rowe-associates-inc

Sequoia Financial Advisors LLC Acquires 13,068 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)

Sequoia Financial Advisors LLC boosted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1,256.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 14,108 shares of the medical research company’s stock after purchasing an additional 13,068 shares […]

United-states , Canada , Williamd-barbo , Shannonm-parisotto , Asia-pacific , Citigroup , Charles-river-laboratories-international-inc , Toroso-investments , Massmutual-trust-co , Manufacturing-solutions , Quarter-for-charles-river-laboratories-international , Wetherby-asset-management-inc